What's in Lipocine Inc.'s pipeline?

Lipocine Inc. has 8 drugs in our index: 0 marketed, 0 filed, 4 in Phase 3, 4 in Phase 2, 0 in Phase 1.

Which companies overlap with Lipocine Inc.'s portfolio?

Top competitors by shared drug class: Abbott, Acerus Pharmaceuticals Corporation, Acrux DDS Pty Ltd, Alliance for Clinical Trials in Oncology, Bayer.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/lipocine-inc.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-06-10 · How we verify

Lipocine Inc. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Lipocine Inc. pipeline: 0 marketed, 0 filed, 4 Phase 3, 4 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 4 Phase 3 4 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Oral testosterone undecanoate, LPCN 1021	Oral testosterone undecanoate, LPCN 1021	phase 3	Androgen replacement therapy	Androgen receptor	Endocrinology
Topical testosterone gel 1.62 %	Topical testosterone gel 1.62 %	phase 3	androgen replacement therapy	androgen receptor	Hormone Replacement Therapy
LPCN 1154A	LPCN 1154A	phase 3	Androgen receptor modulator	Androgen receptor (AR)	Endocrinology
LPCN 1021	LPCN 1021	phase 3	Androgen receptor agonist	Androgen receptor	Endocrinology

Therapeutic area mix

Endocrinology · 3
Hormone Replacement Therapy · 1
Urology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Abbott · 1 shared drug class
Acerus Pharmaceuticals Corporation · 1 shared drug class
Acrux DDS Pty Ltd · 1 shared drug class
Alliance for Clinical Trials in Oncology · 1 shared drug class
Bayer · 1 shared drug class
Beersheva Mental Health Center · 1 shared drug class
Clarus Therapeutics, Inc. · 1 shared drug class
Imperial College Healthcare NHS Trust · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Lipocine Inc.:

Cite this brief

Drug Landscape (2026). Lipocine Inc. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/lipocine-inc. Accessed 2026-06-10.